Health
Metformin use reduces risk of death for patients with COVID-19 and diabetes, study finds – Science Daily
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes,…
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19.”This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure,” said Anath Shalev, M.D., director of UAB’s Comprehensive…
-
General14 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
General19 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
Noosa News19 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
Noosa News24 hours agoQueensland government to set up $400m energy investment fund